← back to database
OMX Ventures backs early-stage companies building transformative biotechnology, life-science tools, therapeutics, diagnostics, and computational-biology platforms. Its core thesis is that engineering and data are accelerating the biology revolution.
Stage focus
Lead / follow
Check size
Ownership target
Specialization
Generalist / Specialist
Specialist
Latest fund size
$150M (Fund I)
Latest fund vintage
2021
Investing team
Craig AsherManaging Director
Dan FeroManaging Director
Nick HaftManaging Director
Swetha MuraliVice President